Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Andersson, S. G. E.
Right arrow Articles by Kurland, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, S. G. E.
Right arrow Articles by Kurland, C. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1988) 22, 605-612
© 1988 The British Society for Antimicrobial Chemotherapy


research-article

Effects of erythromycin base and erythromycin esters on protein synthesis in vivo in Escherichia coli

Siv G. E. Andersson and Charles G. Kurland

Department of Molecular Biology, Biomedical Center Box 590, S-751 24 Uppsala, Sweden

Received 25 March 1988; returned 7 June 1988; accepted 7 June 1988


The inhibitory effects on protein synthesis in vivo of erythromycin base and several erythromycin esters have been determined. An experimental method was used, especially suited for studies on short-lived antibiotics causing low levels of inhibition. Most of the tested derivatives were 2–3% as active as erythromycin base while a split product of erythromycin, anhydroerythromycin, was 4% as effective.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.